Bal Pharma Ltd.
| BSE: 524824 | Sector: Health care |
| NSE: BALPHARMA | ISIN Code: INE083D01012 |
| BSE 00:00 | 16 Apr | 62.40 |
0.15 (0.24%) |
OPEN
63.10 |
HIGH
64.00 |
LOW
61.00 |
| NSE 00:00 | 16 Apr | 62.55 |
-0.10 (-0.16%) |
OPEN
63.50 |
HIGH
64.25 |
LOW
62.15 |
| OPEN | 63.10 |
| PREVIOUS CLOSE | 62.25 |
| VOLUME | 3174 |
| 52-Week high | 73.00 |
| 52-Week low | 33.50 |
| P/E | 160.00 |
| Mkt Cap.(Rs cr) | 92 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Bal Pharma Ltd. (BALPHARMA) - Announcements
-
Bal Pharma Ltd Shareholding for the Period Ended March 31 2021
14/04/2021 | bse
-
Bal Pharma Ltd Compliance With Regulation 7(3) Of SEBI(LODR) Regulations
12/04/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Statement Of Investor Complaints For The Quarter Ended March 2021
05/04/2021 | bse
-
Bal Pharma Ltd Disclosure Reg Large Corporate.
02/04/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Closure of Trading Window
30/03/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Acquisition
23/03/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
22/03/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
22/03/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Outcome Of The Board Meeting
17/03/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Credit Rating
15/03/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Board Meeting Intimation for Allotment Of Shares On Conversion Of Warrants
09/03/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
15/02/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Unaudited Financial Results For The Quarter Ended 31.12.2020
11/02/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Meeting Updates
11/02/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
03/02/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended 31.12.20
20/01/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
15/01/2021 | bse |
Downlaod PDF -
Bal Pharma Ltd Shareholding for the Period Ended December 31 2020
12/01/2021 | bse
-
Bal Pharma Ltd Statement Of Investor Complaints For The Quarter Ended December 2020
04/01/2021 | bse
-
Bal Pharma Ltd Transfer Of Shares To IEPF A/C
29/12/2020 | bse |
Downlaod PDF
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
